Directory
>
Luba Greenwood
Luba Greenwood
EIR at PureTech and CEO of Gallop Oncology | Kojin Therapeutics
Boston, Massachusetts, United States
Luba Greenwood
Summary
Luba Greenwood is a distinguished healthcare and life sciences executive with extensive experience in venture capital and corporate governance. Currently serving as the Chief Executive Officer and Managing Partner at Dana-Farber Cancer Institute Venture Fund, she has successfully led investments exceeding $5 billion across various therapeutic areas and sectors. A former litigator at WilmerHale, Luba has a robust legal background, specializing in corporate law and compliance. She serves on the boards of multiple organizations, showcasing her commitment to leadership and mentorship. Luba is also a lecturer at Harvard University, where she imparts knowledge in engineering and applied sciences. Her passion for innovation is evident in her role as an investor and advisor to emerging biotech and digital health companies. Beyond her professional endeavors, Luba is dedicated to raising awareness for healthcare-related causes through her involvement with organizations like the Longwood Symphony Orchestra.
Luba Greenwood
Work Experience
EIR at PureTech and CEO of Gallop Oncology at
PureTech Health
July 2024 - Present
Podcast Host at
Second Opinion Media
July 2024 - Present
Investor at
NextPoint Therapeutics, Inc.
January 2023 - Present
Director Board of Directors at
Abcam
September 2022 - Present
Investor, Binney Street Capital at
Kojin Therapeutics
June 2021 - Present
Board Member at
In8bio, Inc.
June 2021 - Present
Medical Advisor at
StuffThatWorks
January 2021 - Present
Director Board Of Directors at
BenchSci
December 2020 - Present
Managing Partner, Binney Street Capital Venture Fund at
Dana-Farber Cancer Institute
July 2019 - Present
Lecturer in Engineering Sciences at
Harvard University
June 2019 - Present
Board Director at
Massachusetts Biotechnology Council Inc
March 2018 - Present
Chief Executive Officer at
Kojin Tx
September 2021 - November 2023
Chair Of The Board Of Directors at
Kojin Therapeutics
June 2021 - November 2023
Chief Executive Officer at
Kojin Therapeutics
September 2021 - November 2023
Co-Founder and Board Member at
Luca Biologics, Inc.
March 2019 - October 2023
Board Member at
OS Fund
March 2021 - September 2022
Director Board Of Directors at
Eterna Therapeutics
November 2017 - January 2022
Senior Advisor to the CEO at
Dana-Farber Cancer Institute
April 2019 - December 2020
Head Strategic Business Development and Corporate Ventures, Verily (Google Life Sciences) at
February 2018 - July 2019
Vice President, Global Mergers & Acquisitions and Business Development at
ROCHE LEON HOLDINGS
September 2015 - February 2018
Executive Board Member at
Longwood Symphony Orchestra
January 2010 - June 2016
Venture Partner at
Colt Ventures, Ltd.
January 2015 - October 2015
Vice President, Business Development and Strategy at
AXCELLA SP Z O O
September 2014 - January 2015
Luba Greenwood
Education
Northeastern University, Doctor Of Jurisprudence
Brandeis University, Bachelors
Frequently Asked Questions about Luba Greenwood
What is Luba Greenwood email address?
Luba Greenwood's primary email address is ****@kojintx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Luba Greenwood work for?
Luba Greenwood is a EIR at PureTech and CEO of Gallop Oncology at Kojin Therapeutics, a company specializing in Commercial physical research.
Where Luba Greenwood graduated from?
Luba Greenwood holds a degree in Doctorates from Northeastern University.
How can I directly contact Luba Greenwood?
To contact Luba Greenwood directly, you can use the email address ****@kojintx.com. Complete contact information is available upon registration with Muraena.
Who is Luba Greenwood?
Luba Greenwood is a distinguished healthcare and life sciences executive with extensive experience in venture capital and corporate governance. Currently serving as the Chief Executive Officer and Managing Partner at Dana-Farber Cancer Institute Venture Fund, she has successfully led investments exceeding $5 billion across various therapeutic areas and sectors. A former litigator at WilmerHale, Luba has a robust legal background, specializing in corporate law and compliance. She serves on the boards of multiple organizations, showcasing her commitment to leadership and mentorship. Luba is also a lecturer at Harvard University, where she imparts knowledge in engineering and applied sciences. Her passion for innovation is evident in her role as an investor and advisor to emerging biotech and digital health companies. Beyond her professional endeavors, Luba is dedicated to raising awareness for healthcare-related causes through her involvement with organizations like the Longwood Symphony Orchestra.
Luba`s contact details
****@kojintx.com
**************@harvard.edu
**************@pfizer.com
**************@abcam.com